Zobrazeno 1 - 6
of 6
pro vyhledávání: '"André Lima de Oliveira COSTA"'
Autor:
Bruna do Carmo BARQUETTE, Mariana Coleta Campolina BELO, Rafaela Mafia da Cruz SILVA, André Lima de Oliveira COSTA
Publikováno v:
Infarma: Pharmaceutical Sciences, Vol 29, Iss 2, Pp 124-132 (2017)
Para garantir a eficácia, a segurança e a credibilidade aos medicamentos dispensados à população, as farmácias magistrais devem aplicar as Boas Práticas de Manipulação, de acordo com a Anvisa. Ainda que limitada a aplicação integral das an
Externí odkaz:
https://doaj.org/article/a8ab8523911a48f2b87e9bd8408ceb30
Autor:
André Lima de Oliveira Costa, Paula Cristina Rezende Enéas, Tiago Assis Miranda, Sueli Aparecida Mingoti, Cristina Duarte Vianna Soares, Gerson Antônio Pianetti
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 49, Iss 2, Pp 311-319 (2013)
Mycophenolate mofetil (MMF) and mycophenolate sodium (MPS) are an ester and a salt of mycophenolic acid. They have different kinetic in vivo characteristics due to differences in molecular structures, physicochemical properties and formulations admin
Externí odkaz:
https://doaj.org/article/9e216ee36838466cb9d069150b8cfed0
Autor:
Gerson Antônio Pianetti, André Lima de Oliveira Costa, Paula Cristina Rezende Enéas, Jessica C. Alvesa, Isabela Costa César, Milena Cristina Ribeiro Souza Magalhães, Sílvia Ligório Fialho, Danielle E.R. Souza
Publikováno v:
Brazilian Journal of Health and Pharmacy. 2:38-50
The therapeutic regimen for the treatment of AIDS using efavirenz, lamivudine and tenofovir disoproxil fumarate has demonstrated efficacy and safety. In this work, an analytical method was developed and validated for simultaneous quantitation of efav
Publikováno v:
Brazilian Journal of Health and Pharmacy. 1:26-32
Pharmacopoeia analysis have limited application to manufactures individual product on pharmacies. The efficacy, safety and credibility of these medicines depend mainly on of Good Manufacturing Practice Guidelines, defined by regulatory Agencies. The
Autor:
Paula Cristina Rezende Enéas, Sueli Aparecida Mingoti, André Lima de Oliveira Costa, Cristina Duarte Vianna Soares, Gerson Antônio Pianetti, Tiago Assis Miranda
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences; Vol. 49 No. 2 (2013); 311-319
Brazilian Journal of Pharmaceutical Sciences; Vol. 49 Núm. 2 (2013); 311-319
Brazilian Journal of Pharmaceutical Sciences; v. 49 n. 2 (2013); 311-319
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 49, Iss 2, Pp 311-319 (2013)
Brazilian Journal of Pharmaceutical Sciences, Volume: 49, Issue: 2, Pages: 311-319, Published: JUN 2013
Brazilian Journal of Pharmaceutical Sciences; Vol. 49 Núm. 2 (2013); 311-319
Brazilian Journal of Pharmaceutical Sciences; v. 49 n. 2 (2013); 311-319
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 49, Iss 2, Pp 311-319 (2013)
Brazilian Journal of Pharmaceutical Sciences, Volume: 49, Issue: 2, Pages: 311-319, Published: JUN 2013
Micofenolato de mofetila (MMF) e micofenolato sódico (MPS) são, respectivamente, éster e sal sódico do ácido micofenólico. Os fármacos possuem características farmacocinéticas distintas em função das diferenças na estrutura molecular, nas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8755fe74313df156e23d301d4947528
https://www.revistas.usp.br/bjps/article/view/68962
https://www.revistas.usp.br/bjps/article/view/68962
Autor:
Andre Lima de Oliveira Costa
Publikováno v:
Biblioteca Digital de Teses e Dissertações da UFMGUniversidade Federal de Minas GeraisUFMG.
Mycophenolic acid (MPA) is a specific, non-competitive and reversible inhibitor of inosine monophosphate dehydrogenase. It is marketed as pro-drug mycophenolate mofetil (MMF) in immediate release tablets, as well as sodium mycophenolic (MSD) in enter
Externí odkaz:
http://hdl.handle.net/1843/FARD-82TLBV